Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Eric Lawitz, MD, FAASLD, AGAF,FAPCR,CPI
VP, Scientific and Research Development
The Texas Liver Inst
Poster(s):
083: Pharmacokinetics & Safety of Navitoclax in Hepatic Impairment
Sunday, September 10, 2023
5:00 PM - 7:00 PM
PT